THE USE OF THE SF-36v2® HEALTH SURVEY (SF-36), SF-12v2®, AND SF-6D® IN HEALTH TECHNOLOGY ASSESSMENTS

被引：0
|
作者：
Crowder, L. [1 ]
Lai, L. [2 ]
Batchelder, L. [3 ]
Carty, M. [1 ]
机构：
[1] QualityMetr, Johnston, RI USA
[2] IQVIA, Reading, Berks, England
[3] IQVIA, Swindon, Wilts, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA41
引用
收藏
页码：S361 / S361
页数：1
相关论文
共 50 条
  • [1] Is Health Preference Derived from the SF-36v2 Equivalent to that Measured by the SF-6D Health Survey?
    Lam, Cindy L.
    Wong, Carlos K.
    Lam, Elegance T.
    QUALITY OF LIFE RESEARCH, 2010, 19 : 105 - 105
  • [2] DERIVATION OF INTERPRETATION THRESHOLDS FOR THE SF-36V2® HEALTH SURVEY (SF-36V2) IN RHEUMATOID ARTHRITIS
    Chen, W. H.
    Rendas-Baum, R.
    Lin, X.
    Kosinski, M.
    Bjorner, J. B.
    Bracher, M.
    VALUE IN HEALTH, 2022, 25 (01) : S247 - S247
  • [3] Developing a New Version of the SF-6D Health State Classification System From the SF-36v2: SF-6Dv2
    Brazier, John E.
    Mulhern, Brendan J.
    Bjorner, Jakob B.
    Gandek, Barbara
    Rowen, Donna
    Alonso, Jordi
    Vilagut, Gemma
    Ware, John E.
    MEDICAL CARE, 2020, 58 (06) : 557 - 565
  • [4] The SF-36v2 and SF-12v2 health surveys in New Zealand: norms, scoring coefficients and cross-country comparisons
    Frieling, Margreet A.
    Davis, Walter R.
    Chiang, Grace
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2013, 37 (01) : 24 - 31
  • [5] Content validation of the SF-36v2® Health Survey Acute for use in hypoparathyroidism
    Meryl Brod
    Laura Tesler Waldman
    Aimee D. Shu
    Alden Smith
    Quality of Life Research, 2023, 32 : 1795 - 1806
  • [6] Content validation of the SF-36v2® Health Survey Acute for use in hypoparathyroidism
    Brod, Meryl
    Waldman, Laura Tesler
    Shu, Aimee D.
    Smith, Alden
    QUALITY OF LIFE RESEARCH, 2023, 32 (06) : 1795 - 1806
  • [7] Health economics index SF-6D versus individual scales of the SF-36 -: Results of the national health survey
    Böhmer, S
    Kohlmann, T
    Bellach, BM
    GESUNDHEITSWESEN, 2001, 63 (8-9) : A8 - A8
  • [8] The Discriminative Properties of the SF-6D Compared With the SF-36 and ODI
    Carreon, Leah Y.
    Berven, Sigurd H.
    Djurasovic, Mladen
    Bratcher, Kelly R.
    Glassman, Steven D.
    SPINE, 2013, 38 (01) : 60 - 64
  • [9] THE VALIDITY OF THE EQ-5D, SF-6D, SF-36 AND SF-12 IN MENTAL HEALTH CONDITIONS: A SYSTEMATIC REVIEW
    Papaioannou, D.
    Peasgood, T.
    Brazier, J.
    Parry, G.
    VALUE IN HEALTH, 2011, 14 (07) : A239 - A239
  • [10] PSYCHOMETRIC VALIDATION OF THE SF-36V2® HEALTH SURVEY IN AN AL AMYLOIDOSIS POPULATION
    White, M. K.
    Bayliss, M.
    McCausland, K. L.
    Guthrie, S.
    HAEMATOLOGICA, 2016, 101 : 596 - 596
12345